Disease Information & Support


The Word:


Generic name Cladribine
Pronunciation KLAD-dri-been
Brand name(s), other common name(s) Leustatin®, 2-CdA
Drug type  Antimetabolite
How the drug is given Intravenously (IV)

Cladribine is FDA approved to treat people who have active hairy cell leukemia. It is also used to treat some other types of leukemia and lymphoma.

Side effects needing medical attention: Black, tarry stools; blood in urine or stool; hoarseness; lower back or side pain; painful or difficult urination or unusual decrease in urination; pinhead-sized red spots on skin or rash; fever; chills; cough; shortness of breath; unusual bleeding or bruising; unusual tiredness or weakness; pain or redness at site of injection; stomach pain; swelling of feet or lower legs; unusually fast heartbeat; fatigue; nausea; decreased appetite; vomiting; diarrhea; constipation; headache; itching; muscle or joint pain; sweating; trouble sleeping; weakness.


For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.

last updated on Monday, October 15, 2012